New Partnership Brings Google Contact Lens Closer to Reality

Swiss healthcare giant Novartis (NYSE: NVS) is known for its many powerful brands. Ritalin, Excedrin, Lamisil and Theraflu are just some of its products that have become household names.

News broke this week that Google (Nasdaq: GOOGL) will soon become another brand associated with Novartis.

I wrote about the innovative Google contact lens concept in January. The two companies, each a titan of its industry, are teaming up and the alliance brings the Google contact lens closer to reality.

In its initial form the Google contact lens will serve one major function: painless and real time monitoring of glucose levels for diabetics.

But the press release alluded to another potentially groundbreaking application, “accommodative vision correction.” Rather than switching between reading glasses and regular glasses, these lenses could adjust based on what you’re looking at.

Novartis’ Alcon division, known best for its contact lens solutions pictured below, will provide medical expertise and a wealth of experience in the field of ophthalmology. Besides medicated eye care solutions and contact lens solutions, the company also produces equipment used for eye surgeries.

google-contact-lens

Source: Novartis.com

For its part, Google brings the smart contact lens concept developed by its secretive Google X division. It also brings considerable expertise with miniature electronics and low-power computer chips.

With Google’s creative and technological foundations and Novartis’ knowledge and experience in the field of eye care, the Google contact lens is quickly moving from pipe dream to marketable product.

The press release announcing the deal specifically pointed to this synergy.

Google’s key advances in the miniaturization of electronics complement Novartis’ deep pharmaceuticals and medical device expertise.

The plan is for Novartis’ Alcon to license and market Google’s “smart lens” technology. And the product has a huge potential market.

Diabetes rates are rising fast.

Already, 29 million people in the United States and 382 million people around the globe suffer from diabetes, an illness that requires frequent – and frequently painful – monitoring of glucose levels.

By measuring tear fluid around the eye via a contact lens rather than analyzing small blood samples, the Google contact lens has the potential to make life easier for millions around the globe. Plus, because glucose levels can fluctuate between tests, real-time monitoring also has the potential to save and improve lives.

Novartis hopes to have a prototype ready by early 2015. But with almost 400 million people suffering from diabetes now, the pressure is on for Google and Novartis to bring a product to market.

The important thing is this: though it seemed like sci-fi only a couple years ago, the Google contact lens is closer than ever.

The New American Prius is a Pick Up Truck

Yes. That’s right. A bigger, better, beefier vehicle is rolling off the assembly line – an American truck that’s actually more efficient than the Toyota Prius. Hey, it can even tow five of them. And it’s not a wimpy hybrid. It’s a 302hp heavy-duty beast. Yet, it only costs around $15 bucks to fill up! And you can travel 800 miles on one tank. That’s why we call it the “American Prius.” ONLY ONE COMPANY has the breakthrough technology for building this truck. And now you can share in their massive profits. Click here to get a full report on this truck and the company building it.

Published by Wyatt Investment Research at